Xirong Guo

机构：Shanghai Jiao Tong University, Tongren Hospital · ORCID：0000-0002-3873-8233

发表论文 322 篇 · 总被引 8584 次 · h-index 47

代表论文

• Circulating Ism1 Reduces the Risk of Type 2 Diabetes but not Diabetes-Associated NAFLD (2022 · Frontiers in Endocrinology · 被引 23)
• Obesity related microRNA‑424 is regulated by TNF‑α in adipocytes (2020 · Molecular Medicine Reports · 被引 16)
• Approaches to addressing the rise in obesity levels (2022 · Nature Reviews Endocrinology · 被引 14)
• Metabolic remodeling of glycerophospholipids acts as a signature of dulaglutide and liraglutide treatment in recent-onset type 2 diabetes mellitus (2023 · Frontiers in Endocrinology · 被引 10)
• Human milk derived peptide AOPDM1 attenuates obesity by restricting adipogenic differentiation through MAPK signalling (2020 · Biochimica et Biophysica Acta (BBA) - General Subjects · 被引 9)
• Metabonomics profile analysis in inflammation-induced preterm birth and the potential role of metabolites in regulating premature cervical ripening (2022 · Reproductive Biology and Endocrinology · 被引 5)